Worldwide Human Growth Hormone Treatment & Drugs Industry to 2032 – by Route of Administration, Application, Distribution Channel and Region – ResearchAndMarkets.com

Jennifer E. Engen

DUBLIN–(BUSINESS WIRE)–The “Global Human Growth Hormone Treatment & Drugs Market 2022-2032” report has been added to ResearchAndMarkets.com’s offering. A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics. After […]

Worldwide Human Growth Hormone Treatment & Drugs Industry to 2032 – by Route of Administration, Application, Distribution Channel and Region – ResearchAndMarkets.com | Nation/World

Jennifer E. Engen

DUBLIN–(BUSINESS WIRE)–Jun 2, 2022– The “Global Human Growth Hormone Treatment & Drugs Market 2022-2032” report has been added to ResearchAndMarkets.com‘s offering. A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important […]

Tribe Property Technologies Announces Partnership with TUT Fitness Group, Bringing Affordable Gym Equipment and Community Wellness Application to Communities Across Canada

Jennifer E. Engen

/NOT FOR DISTRIBUTION IN THE U.S. OR TO U.S. NEWSWIRE SERVICES/ VANCOUVER, BC, March 9, 2022 /CNW/ – Tribe Property Technologies (TSXV: TRBE) (OTCQB: TRPTF) (“Tribe” or the “Company”) has partnered with TUT Fitness Group (TSXV: GYM) (Frankfurt: 7PG) (“TUT”) a Canadian manufacturer of high-performance and affordable fitness products, to […]

Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency

Jennifer E. Engen

NEW YORK & MIAMI–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the […]